In vivo Tracking of Mesenchymal Stem Cells Labeled with a Novel Chitosan-coated Superparamagnetic Iron Oxide Nanoparticles using 3.0T MRI by Reddy, Alavala Matta et al.
INTRODUCTION 
Stem cell therapy will improve preventive and therapeu-
tic care of many devastating diseases with the replacement
of defective or injured tissues (1). The survival and proof of
homing and engraftment of transplanted stem cells in the
target tissues or organs is critical for the success of cell ther-
apy (2). Biochemical or immunohistochemical analysis of
biopsy or autopsy of tissue may give partial or simple ‘‘snap
shot’’ information about the fate of transplanted cells. But a
real time fate of transplanted cells may be known by nonin-
vasive magnetic resonance (MR) imaging, provided the cell
are labeled with an MR contrast agent before transplantation.
Cellular MR imaging using superparamagnetic iron oxide
(SPIO) as contrast agent offers high spatial resolution down
to submillimeter range. Iron oxide nanoparticles are usually
stabilized by coating with polymeric layer using dextran, car-
boxydextran, starch, albumin, silicones or polyethylene gly-
col to overcome the problem of particle aggregation due to
large surface-to-volume ratio (3, 4). Resovist is a clinically
approved MR contrast agent that is coated with carboxydex-
tran. In our previous study, SPIO nanoparticles were synthe-
sized by coating with chitosan (5, 6). Chitosan is a biodegrad-
able natural polymer which is useful for many biological appli-
cations due to its biocompatibility, high charge density, non-
toxicity, gelling property and ability to improve dissolution
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In vivo Tracking of Mesenchymal Stem Cells Labeled with a Novel
Chitosan-coated Superparamagnetic Iron Oxide Nanoparticles using
3.0T MRI
This study aimed to characterize and MRI track the mesenchymal stem cells labeled
with chitosan-coated superparamagnetic iron oxide (Chitosan-SPIO). Chitosan-SPIO
was synthesized from a mixture of FeCl2 and FeCl3. The human bone marrow deriv-
ed mesenchymal stem cells (hBM-MSC) were labeled with 50 mg Fe/mL chitosan-
SPIO and Resovist. The labeling efficiency was assessed by iron content, Prussian
blue staining, electron microscopy and in vitro MR imaging. The labeled cells were
also analyzed for cytotoxicity, phenotype and differentiation potential. Electron micro-
scopic observations and Prussian blue staining revealed 100% of cells were labeled
with iron particles. MR imaging was able to detect the labeled MSC successfully.
Chitosan-SPIO did not show any cytotoxicity up to 200 mg Fe/mL concentration. The
labeled stem cells did not exhibit any significant alterations in the surface markers
expression or adipo/osteo/chondrogenic differentiation potential when compared
to unlabeled control cells. After contralateral injection into rabbit ischemic brain, the
iron labeled stem cells were tracked by periodical in vivo MR images. The migra-
tion of cells was also confirmed by histological studies. The novel chitosan-SPIO
enables to label and track MSC for in vivo MRI without cellular alteration.
Key Words : Chitosan; Mesenchymal Stem Cells; Superparamagnetic Iron Oxide; Magnetic Resonance Imag-
ing; Brain Ischemia 
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distribution, and reproduction in any medium, provided the original work is properly cited.(7). Chitin, a poly (-[1,4]-N-acetyl-D-glucosamine), is the
second most abundant natural biopolymer after cellulose, and
it is abstracted from the crust of crabs and shrimp. Chitosan
can be prepared by N deacetylation of chitin. 
The purpose of this study is to analyze the functional capac-
ity of mesenchymal stem cells (MSC) after labeled with chi-
tosan-SPIO compared to clinically approved MR contrast
agent, Resovist and to detect the transplanted MSC in the
rabbit ischemic brain by in vivo MRI.
MATERIALS AND METHODS
Characteristics of SPIOs
As was mentioned in our previous study (5, 6), chitosan
coated superparamagnetic iron oxide (Chitosan-SPIO) nano-
particles were synthesized by sonochemical method followed
by chitosan coating process. Transmission electron microscopy
indicated that Chitosan-SPIO nanoparticles are spherical and
crystalline. The physical properties of Chitosan-SPIO are as
follows: the mean core iron size is 6 nm, the hydrodynamic
size including the chitosan coat is 65 nm. The clinically ap-
proved MR contrast agent, carboxydextran-coated SPIO (Reso-
vist; Schering AG, Berlin, Germany) was used for compari-
son. These values of Resovist (mean core size 4.2 nm, mean
hydrodynamic size 62 nm) are similar to those of Chitosan-
SPIO (8). 
MR phantom study
MR phantom studies were conducted using aqueous solu-
tion of Resovist and Chitosan-SPIO compounds in 4 mL plas-
tic bottle with iron concentration ranging from 0.03-100 mg
Fe/mL. The samples were placed in a plastic box containing
distilled water to obtain T2 weighted images (turbo spin echo;
TR 2,128 msec, TE 80 msec, FOV 230×230 mm, matrix
700×625, 1-mm thickness, number of excitation 8, resolu-
tion 0.32×0.37×1.0 mm) using a 3.0 T MR system (Intera
Achieva; Philips, Eindhoven, The Netherlands). The signal
intensities of the SPIO samples were determined from a 30-
mm2 region of interest. The MR signal intensities of 3 repli-
cates were plotted against the different concentration of SPIO.
Cell cultures
Mesenchymal stem cells derived from human bone mar-
row (#PT-2501, Cambrex Bio Science, Rockland, ME, USA)
were grown in DMEM that contain 10% fetal bovine serum,
200 mM L-glutamine, and 1% antibiotic-antimycotic (Invit-
rogen, Carlsbad, CA, USA) at 37℃ and in 5% CO2 atmo-
sphere. The culture medium was changed every 3-4 days once
and the cells were sub-cultured at 80-90% growth conflu-
ence.
Iron labeling of cells
The polyamine, Poly L-lysine hydrobromide (PLL) of molec-
ular weight 388,100 d (#P1524, Sigma, St. Louis, MO, USA)
was used as the transfection agent to facilitate the endocyto-
sis of SPIO nanoparticles into the mesenchymal stem cells.
In order to facilitate binding iron particles with transfection
agent, PLL at 1.5 mg/mL and SPIO at 100 mg Fe/mL concen-
trations, both prepared in culture medium were gently shak-
en for 60 min. The MSC were supplied with culture media
containing the SPIO-PLL complex such that one milliliter
of medium contain 50 mg Fe/mL SPIO and 750 ng/mL PLL
as final concentration to ensure labeling (50 mg Fe/mL SPIO
was equivalent to 8.81 mg Fe/cm2 surface area in culture dish).
The cell cultures were incubated overnight at 37℃ in a 5%
CO2 atmosphere. The cells were treated with 3.1-1,600 mg
Fe/mL of SPIO nanoparticles for dose response study, and
time-course study was performed at 25 and 100 mg Fe/mL
concentrations. All the experiments were conducted with at
least three replicates.
Iron staining of cells
Prussian blue staining was performed to localize the iron
particles in SPIO labeled MSC or rabbit tissues that received
MSC. The iron labeled cells were washed twice with phos-
phate buffered saline (PBS) to remove excess contrast agent,
fixed with 4% glutaraldehyde, again washed and incubated
for 30 min with 2% potassium ferrocyanide in 6% hydrochlo-
ric acid. After washing 3 times with PBS, the cells were coun-
terstained with nuclear fast red. 
Electron microscopic studies
The SPIO-labeled cells (1.5×106) were fixed in 3% glu-
taraldehyde-cocadylate buffer at 4℃ overnight. After an hour
incubation in 1% OsO4 the cells were dehydrated in graded
dilutions of ethanol, embedded in artificial resin (Epon; Merck,
Darmstadt, Germany), and processed for electron microscopy.
Thin sections of the cell probes were evaluated unstained to
prevent false-positive findings. Electron microscopy (EM 10
CR; Carl Zeiss, Oberkochen, Germany) was performed at
60-80 kV. Unstained thin sections were evaluated for endo-
cytosis of SPIO nanoparticles.
Iron estimation
The iron accumulation by labeled cells was assessed by
inductively coupled plasma-atomic emission spectroscopy
(ICP-AES, JY Ultima 2; Jobin Yvon, Longjumeau, France).
SPIO-labeled MSC were digested in 400 mL cocktail of sul-
phuric acid and hydrogen peroxide (1:2) at 100℃ for 18 hr
using oil bath. The colorless digested acid solution was made
up to 5 mL and undissolved impurities were removed by fil-
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plotted using Iron AA standard solution (Aldrich, Milwau-
kee, WI, USA). The iron content of samples was expressed
in pg of Fe per cell. 
In vitro cellular MR Imaging
SPIO labeled cells (5×105) were washed twice with PBS
and centrifuged to get cell pellet in Eppendorf tube to obtain
T2*weighted image (gradient echo) of cell pellet along with
the PBS supernatant using 3.0 T MR system (Intera Achie-
va; Philips). Images were taken by using TR 30 msec, TE
13.8 msec, FA 15°, FOV 128×128 mm, matrix size 512×
512, 1-mm thickness, number of excitation 2 and 0.25×
0.25×1.0 mm resolution. 
Cell viability
WST-8 Cell Counting Kit-8 (#CK04; Dojindo Laborato-
ries, Kumamoto, Japan) was used to evaluate the viability of
SPIO-labeled MSC in three replicates. The human MSC were
grown in 96-well plates at 5,000 cells in 200 mL culture medi-
um per well. Cells were labeled with the Iron oxide-PLL com-
plex overnight at 37℃ in a 5% CO2 atmosphere. Unlabeled
cells which were kept under identical conditions served as
control cells. After overnight incubation, 20 mL of WST-8
solution per well was added to the growing cells and were
incubated for an additional 1-4 hr. The absorbance of the for-
mazen product was then measured at a wavelength of 450
nm subtracting absorbance at 600 nm or above according
to manufacturer’s instructions.
Immune phenotypic analyses
Human MSC at 4-5 passages were labeled overnight with
chitosan-SPIO nanoparticles or Resovist at 25 and 100 Fe mg/
mL, washed twice in PBS and maintained in culture medi-
um for one week. To verify if the SPIO-labeling process affect-
ed the cell-surface expression of typical marker proteins, both
unlabeled and SPIO-labeled MSC were incubated with anti-
human antibodies. The cells were analyzed using CD44-PE,
CD73-PE (Becton Dickinson, Heidelberg, Germany), CD29-
FITC, CD105-PE, CD166-PE (Beckman Coulter, Miami,
FL, USA) antibodies as positive markers, and CD14-FITC,
CD34-PE, CD45-FITC (Beckman Coulter) as negative mark-
ers. Mouse isotype antibodies served as respective controls
(Becton Dickinson and Beckman Coulter). Ten thousand anti-
body-labeled cells were acquired and analyzed using a Cyto-
mics FC 500 flow cytometer running CXP software (Beck-
man Coulter).
Adipogenic differentiation study
For inducing adipogenic differentiation, both unlabeled
and SPIO-labeled MSCs were cultured in NH AdipoDiff
Medium (Miltenyi Biotec, Bergisch Gladbach, Germany) for
3 weeks in eight-chamber slides (Nunc, Naperville, IL, USA)
by changing medium twice a week. The induction of adi-
pogenic differentiation was apparent by intracellular lipid-
rich vacuoles that can be seen under a light microscope. Lipid
vacuoles of cells were detected by staining with Oil Red O
(Sigma). Formalin fixed cells were washed and stained with
0.18% Oil Red O for 5 min and counterstained with hema-
toxylin to find red colored lipids and blue nuclei.
Osteogenic differentiation study
For inducing osteogenic differentiation, SPIO-labeled MSCs
were cultured in NH OsteoDiff Medium (Miltenyi Biotec)
using eight-chamber slides (Nunc) for 3 weeks changing
media twice a week. The osteogenic differentiation was eval-
uated by the calcium accumulation that was detected by von
Kossa staining with modifications (9). The cells were fixed
in 10% formalin, washed and were incubated with 5% silver
nitrate (Sigma) under UV light for 15 to 30 min. To devel-
op and fix the signal, 1% pyrogallal and 5% sodium thiosul-
fate were used, followed by counterstaining with nuclear fast
red. Staining gave brownish black color to calcium deposits
and red color to nuclei. 
Chondrogenic differentiation
For inducing chondrogenic differentiation, 2.5×105 SPIO-
labeled cells were centrifuged at 150 g for 5 min in a 15-mL
polypropylene tube (Falcon, Rockfalls, NJ, USA) to form a
pellet (10) and cultured in complete NH ChondroDiff Medi-
um (Miltenyi Biotec) without disturbing the pellet. The medi-
um was changed 2 times a week for 3 weeks. The pellets were
fixed in 10% formalin, embedded in paraffin blocks, and ana-
lyzed by Alcian Blue staining. The deparaffinized sections
were stained for 30 min with 1% Alcian Blue solution (pH
1.0) to blue colored cartilaginous elements. Cell nuclei were
counterstained with nuclear fast red that gives red or pink
color.
In vivo MRI of MSC in rabbit brain
Ischemic condition in rabbit brain was created by infusion
of 150-250 mm polyvinyl alcohol particles (Contour; Boston
Scientific, Natick, MA, USA) through a microcatheter (Micro-
ferret-18 Zeta; William Cook Europe, Bjaeverskov, Denmark)
which was inserted through right femoral artery till occlud-
ing the left internal carotid artery. On day 4 of ischemia, by
directly inserting 1-mL syringe with 25 G needle through
burr hole using Stoelting stereotaxic system (Stoelting, Wood
Dale, IL, USA), 106Chitosan-SPIO-labeled MSCs were inject-
ed into the contralateral right hemisphere of rabbit brain. A
series of in vivo MR images including T2 weighted (turbo
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thickness 1.5 mm, matrix 224×205, number of excitation
8), diffusion weighted (TR 4,763 msec, TE 50 msec, FOV
80×80 mm, thickness 1.5 mm, matrix 96×94, number of
excitation 3) and susceptibility weighted (TR22.6, TE 32.6,
FA 10.0, FOV 100×100 mm, thickness 1.4 mm, matrix
144×144, number of excitation 1) images were taken on
1, 8, 11, 17 days after stem cell transplantation. On day 17
the rabbits were sacrificed, brains were harvested and fixed
in 4% paraformaldehyde for histological studies.
RESULTS
MR phantom studies
MR signal intensities in terms of arbitrary values were obta-
ined from each image of Resovist and Chitosan-SPIO at 0.03-
100 mg Fe/mL concentrations using an MR system (Philips)
and the intensities for 3 replicates were plotted against the
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Fig. 1. Comparative MR phantom study of Resovist and chitosan
coated SPIO showing similar relation between signal intensity and
iron concentration on T2 weighted image.
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Fig. 2. In vitro evaluation of iron labeling of mesenchy-
mal stem cells by cellular MRI that show labeled cells
indicated by arrows (A), Prussian blue staining of in vitro
cultured cells (B) and electron microscopic images that
show internalized SPIO nanoparticles (C). 
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A
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Chitosan-SPIO-MSC, ×10,000range of SPIO concentrations (Fig. 1). The MR signals dropp-
ed gradually from 0.03 to 100 mg Fe/mL concentrations and
both compounds followed a similar trend.
In vitro evaluation of iron labeling
To visualize the cells through in vitro MRI, the SPIO-la-
beled MSC were centrifuged to a pellet in microtubes. Iron
labeled cells emitted a dark signal in T2* weighted image
but not unlabeled control cells (Fig. 2A). Further Prussian
blue staining of SPIO labeled MSC to detect internalization
of iron reveals that almost all the cells were labeled efficient-
ly with Chitosan-SPIO as well as with Resovist at 50 mg Fe/
mL concentrations (Fig. 2B). Endocytosis of SPIO particles
was also clearly evident through electron microscopic stud-
ies (Fig. 2C). Dark colored SPIO crystals were located in cyto-
plasmic vacuoles at 8,000-10,000×magnification. The iron
loaded cells did not show any abnormal structural changes.
ICP-AES data for iron estimation reveals that similar amounts
of iron (approximately 18 pg per cell) was taken up by MSC
when labeled with Chitosan-SPIO or Resovist iron particles
(Table 1). 
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MSC, mesenchymal stem cell.
Samples Amount of Fe (pg/cell)
Unlabeled MSC 3.2±0.21
Resovist MSC 17.9±0.08
Chitosan-SPIO MSC 17.8±0.20
Table 1. Iron content in mesenchymal stem cells one day after
50 mg/mL iron labeling (pg/cell±SD). All data are expressed
as mean±SD of at least 5 samples
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Dose response of SPIO nanoparticles ranging 3.1-1,600 mg
Fe/mL concentrations on cell viability was studied using Reso-
vist and Chitosan-SPIO (Fig. 3A). Resovist and Chitosan-
SPIO compounds appear to be safer and did not show any
cytotoxicity below 200 mg Fe/mL concentration. However
the concentrations of SPIO compounds used in this study
were 100 mg Fe/mL or less. Cell viability of iron labeled cells
was also monitored until 3 weeks in a time course study after
labeling the cells with 25 and 100 mg Fe/mL of SPIO and did
not find any significant differences in proliferation compared
to control cells (Fig. 3B). FACS immunophenotypic analysis
reveals that positive cell surface markers, CD29, CD44, CD73,
CD105, and CD166 or negative markers, CD14, CD34, and
CD45 of MSC were not altered due to iron labeling with Chi-
tosan-SPIO or Resovist (Fig. 4, Table 2). But a little increase
in CD34 marker expression has been observed due to label-
ing cells with 100 mg Fe/mL of Chitosan-SPIO. 
Differentiation capacity
To verify if the iron labeling affected the differentiation capac-
ity, adipogenic, osteogenic and chondrogenic differentiation
was induced with iron labeled MSC. MSC labeled with 100
mg Fe/mL of SPIO underwent adipogenic differentiation as
efficiently as unlabeled cells that apparent from red colored
lipid vacuoles following Oil red O staining (Fig. 5A, B). Also,
iron labeling did not affect the osteogenic differentiation poten-
tial of MSC (Fig. 5C, D). There were no significant differences
found between Resovist and Chitosan-SPIO compounds per-
taining to adipogenic or osteogenic differentiation capacity.
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MSC, mesenchymal stem cell.
CD 
markers
Unlabeled
MSC
Resovist MSC
25* 100*
Chitisan-SPIO MSC
25* 100*
CD29 99.9 99.9 99.9 99.9 99.7
CD44 100 99.9 99.9 100 99.8
CD73 99.9 99.9 99.9 99.9 99.6
CD105 99.9 99.9 99.9 100 100
CD166 99.9 100 100 100 99.9
CD14 0 0 0 0 0
CD34 5.2 6.6 5.7 5.7 21.3
CD45 0.7 1.8 1.7 1.7 0.7
Table 2. Cell surface marker analysis of chitosan-SPIO-labeled
mesenchymal stem cell. Comparative analysis of both positive
(CD29, 44, 73, 105, and 166) and negative (CD14, 34, and 45)
cell surface markers in unlabeled and SPIO-labeled (25 or 100
mg Fe/mL) mesenchymal stem cell (unit, %)
B1 B2
B3 B4
B1 B2
B3 B4
B1 B2
B3 B4
B1 B2
B3 B4
B1 B2
B3 B4
B1 B2
B3 B4
B1
B3 B4
B1 B2
B3 B4
CD44 CD73
CD105
CD45
CD166 CD14 CD34
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Fig. 5. Differentiation potential of Resovist and chitosan-SPIO labeled mesenchymal stem cells. Iron (100 mg Fe/mL) labeled MSC were
exposed to adipogenic (A, B), osteogenic (C, D) and chondrogenic differentiation media (E, F) for 3 weeks. Red colored oil granules are
detected by Oil red O staining in adipogenic cultures of Resovist (A) and chitosan-SPIO labeled mesenchymal stem cells (B). Calcium min-
eralization is detected by von Kossa staining in osteogenic cultures of MSC labeled with Resovist (C) or chitosan-SPIO (D). Alcian Blue
staining reveals that chitosan-SPIO labeled MSC (F) exhibit chondrogenic differentiation (asterisk, blue color), but not Resovist labeled
cells (E).
Fig. 6. In vivo MRI of rabbit ischemic brain that received chitosan-SPIO labeled mesenchymal stem cells. Asterisk indicates ischemic area
and open arrows indicate chitosan-SPIO-labeled mesenchymal stem cells at the injection site. (A, B) T2WI and diffusion weighted image
(DWI) of brain immediately after injection of mesenchymal stem cell at contralateral side of ischemic area (open arrows) on day 4 of ischemia.
(C, D) T2WI and susceptibility weighted image (SWI) 16 days after stem cell transplantation. At the ischemic site, dark signal (white arrows)
especially on SWI matches mesenchymal stem cells (black arrows) on Prussian staining (E, F). (E, F) Prussian blue staining detected iron
labeled stem cells at the liquefied infarct area in a section of 4% paraformaldehyde-fixed brain tissue on day 16.
A B C
A B C
D E F
D E F
*
* *But chondrogenesis was greatly inhibited by Resovist but
not by Chitosan-SPIO, which is evident from Alcian blue
staining (Fig. 5E, F). Iron particles were detected by Prus-
sian blue staining in chondro-induced masses 3 weeks after
labeling. 
In vivo MRI detection of SPIO labeled cells
Brain ischemic condition in rabbit was generated by infu-
sion of polyvinyl alcohol particles into internal carotid artery
at one side. At day 4, MSC that are labeled with 50 mg Fe/
mL chitosan-SPIO were injected into contralateral position
of brain and the ischemic site as well as transplanted stem
cells were visualized by T2WI (Fig. 6A) and diffusion weight
image (DWI) (Fig. 6B) images. At day 16, T2WI (Fig. 6C)
and susceptibility weighted image (SWI) (Fig. 6D) were used
to visualize the stem cell fate. Many of the transplanted stem
cells were located at the injected site but some of them migrat-
ed to the ischemic site which is more evident from SWI (Fig.
6D). The size of ischemic area was decreased when compared
to that of day 4 (Fig. 6A-D). To verify the MRI results brain
slices were stained with Prussian blue stain and found SPIO
labeled stem cells in the tissue (Fig. 6E, F).
DISCUSSION 
The results of this study demonstrated that the chitosan-
SPIO labeling does not alter the proliferation, surface marker
expression or differentiation capacity of MSC and the labeled
cells can be visualized in the post-ischemic rabbit brain by
MRI. Resovist labeling also did not alter functional capaci-
ty of MSC except chondrogenesis. The core size of SPIO par-
ticles coated with chitosan is approximately 10 nm but only
4.2 in carboxydextran coated Resovist. 
A gradual concentration dependent signal-drop was found
in MR phantom study that is consistent with previous report
(11). Poly-L-Lysine mediated incorporation of chitosan-SPIO
into endosomes of cell is a simple but efficient method that
enables almost 100% of the cells to be labeled. Efficient label-
ing of various kinds of cells was also performed by several
others using various kinds of transfection agents (12-14). Iron
labeling efficiency was evaluated by in vitro cellular MRI,
Prussian blue staining, electron microscopy and iron estima-
tion. There is no significant difference found in labeling effi-
ciency with chitosan-SPIO and Resovist. As was reported
by others with some iron particles (13, 15), chitosan-SPIO
or Resovist also did not affect the cell viability, proliferation,
surface marker expression and adipogenic and osteogenic dif-
ferentiation potential. All the experimental SPIO concentra-
tions were maintained below 100 mg Fe/mL, since chitosan-
SPIO and Resovist appear cytotoxic beyond 200 mg Fe/mL
concentrations. Chitosan-SPIO labeling did not affect the
chondrogenic potential of MSC, however Resovist did affect.
Few reports of recent past made the chondrogenesis of feridex
labeled MSC described that inhibition of chondrogenesis by
feridex labeling could be corrected by using protamine sul-
fate as transfection agent instead of PLL (13, 15-17). In this
study chondrogenesis was not inhibited by chitosan-SPIO but
inhibited by Resovist when PLL used as transfection agent.
Further studies on the exact molecular mechanism of chon-
drogenesis in SPIO labeled MSC are warranted. PLL seems
not to interfere with chondrogenesis of MSC (15). Although
Arbab et al. (17) attributed the inhibition of chondrogenesis
to PLL they did not substantiate well how PLL can prevent
chondrogenesis.
MR images (T2W, DW, and SW) of rabbit brain before
and after transplantation of cells are able to detect brighter
ischemic area and darker chitosan-SPIO labeled MSC. Prus-
sian blue staining confirmed the existence of labeled stem
cells in the brain tissue. Previous studies were able to trace
the transfused CD34-positive cells (18), mononuclear cells
(19) and cord blood cells (20) following brain ischemia. This
study shows that chitosan-SPIO labeling does not interfere
with cell functions and in vivo MRI is able to trace iron labeled
cells following transplantation.
For in vivo MR imaging chitosan-SPIO labeling of MSC
using PLL as transfection agent did not have any toxic effects
on viability or proliferation up to 3 weeks. The iron labeling
did not alter the cell surface markers or differentiation capac-
ity including chondrogenesis of MSC when compared to clin-
ically approved Resovist. In the context of serious debate on
the effect of SPIO labeling on chondrogenesis (16), chitosan-
SPIO labeled MSC did not alter the chondrogenic differen-
tiation capacity of MSC. Further in vivo MR imaging by
T2WI, DWI, and SWI enabled to track the chitosan-SPIO
labeled MSC in brain ischemic rabbit model up to 2 weeks.
Therefore chitosan-SPIO may potentially become a better
MR contrast agent especially to track the transplanted stem
cells and other cells without compromising cell functional
quality.
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